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Highlights 
 Empirically-grounded conceptual Framework of DM with a corresponding graphical aid  
 Focuses on the form and extent of family caregiver involvement in/influence over DM 
 Presents six conceptual insights derived from empirical evidence and DM theory 
 May serve as a useful guide for future empirical, ethical and/or theoretical work 
Abstract 
Objective: Family caregivers are regularly involved in cancer consultations and treatment decision-
making (DM). Yet there is limited conceptual description of caregiver influence/involvement in DM. 
To address this, an empirically-grounded conceptual framework of triadic DM (TRIO Framework) 
and corresponding graphical aid (TRIO Triangle) were developed.   
    
Methods: Jabareen’s model for conceptual framework development informed multiple phases of 
development/validation, incorporation of empirical research and theory, and iterative revisions by 
an expert advisory group.  
 
Results: Findings coalesced into six empirically-grounded conceptual insights: i) Caregiver 
influence over a decision is variable amongst different groups; ii) Caregiver influence is variable 
within the one triad over time; iii) Caregivers are involved in various ways in the wider DM process; 
iv) DM is not only amongst three, but can occur among wider social networks; v) Many factors may 
affect the form and extent of caregiver involvement in DM; vi) Caregiver influence over, and 
involvement in, DM is linked to their everyday involvement in illness care/management.  
    
Conclusion: The TRIO Framework/Triangle may serve as a useful guide for future empirical, 
ethical and/or theoretical work.  
 
Practice Implications: This Framework can deepen clinicians’s and researcher’s understanding of 
the diverse and varying scope of caregiver involvement and influence in DM.  
 
 
 
Keywords: 
family caregivers; triadic; medical decision-making; conceptual framework; 
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1. Introduction 
Family caregivers regularly attend cancer consultations with an adult patient (accompaniment 
rates range from 64-86%) [1, 2]. Typically one key family caregiver attends, and this is usually the 
patient’s spouse/partner or adult child (less commonly a patient’s parent, sibling, other relative or 
friend) who is involved in the care of the patient [3]. This key family caregiver also often 
participates in the decision-making (DM) process [4]- some in a supportive or facilitative capacity, 
while others are involved more directly in DM.  
The involvement of family caregivers in DM may be particularly important among some families, as 
medical decisions often impact not only the patient, but also the family caregiver [5, 6]. For 
example, the spouse of a young adult patient is likely to be directly impacted by a decision to 
undergo treatment which affects fertility. Correspondingly, daily life will be affected for the adult 
child caregiver of an elderly patient who decides to receive daily outpatient treatment requiring 
transportation and accompaniment to the hospital. Finally, family caregivers will be impacted by a 
decision for the patient to receive home-based palliative care and die at home. Despite the frequent 
involvement of family caregivers in consultations and decisions, most conceptual papers discussing 
medical DM published to date have focused on the clinician-patient dyad [see 7] rather than the 
clinician-patient-family caregiver triad and larger social networks. However, a growing empirical 
literature acknowledges the significant role of family caregivers in medical DM. 
Most cancer patients (49-84%) and family caregivers (54-59%) report both preferring and 
experiencing some family caregiver involvement in DM [8-12]. However the form and extent of 
family involvement in DM appears to vary widely. Most patients and family caregivers prefer 
family caregivers’ involvement to be facilitative or collaborative [9, 12], and this preference is 
reflected in practice.  In a US study examining the experiences of over 5,000 patients with lung and 
colorectal cancer, 1.5% of the sample reported their family made important decisions on their 
behalf, 49.4% reported equally sharing decisions with family, 22.1% reported some family 
involvement, and 28.5% of patients reported little or no role for their family in DM. Interaction 
analyses of audio/video-taped medical consultations similarly highlight that family caregivers are 
often actively involved in consultation communication [e.g. 2, 13], and DM [13-15]; and also reveal 
that family caregiver involvement in DM is variable both across consultations and among different 
triads [13]. Family caregiver involvement in DM can vary on a spectrum from passive to dominant 
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[4, 16, 17] and the form/extent of involvement may be influenced by contextual factors such as the 
patient’s age, gender, health status, cultural background and relationship with the family caregiver 
[11, 18]. Despite the growing empirical evidence base, there remains limited conceptual description 
of family caregiver involvement in DM.  
1.1 Conceptual frameworks of family caregiver involvement in DM 
Whilst the majority of conceptual publications to date have focused on the clinician-patient dyad, 
some more recent publications have started to acknowledge the importance of significant others, 
including family caregivers. For example, Rapley’s [19] account of ‘distributed DM’ highlights that 
decisions are embedded within and are shaped by social interactions, which can include family and 
friends within and outside the medical consultation. Addionally, Epstein and Street’s [20] concept 
of ‘shared mind’ proposes that decisions may be made within social networks, where new ideas and 
perspectives may emerge through the sharing of thoughts and feelings between individuals 
(including family and friends of a patient). Elwyn et al.’s [21] model of collaborative deliberation 
similarly acknowledges that DM is not usually done in isolation and recognises the value of 
collaboration between individuals (including clinicians, family, and friends). Additionally, Légaré et 
al.’s [22] Interprofessional Shared DM model (IP-SDM) explains that many members of the inter-
professional team as well as family caregivers are involved in the treatment DM process. Whilst 
these conceptual publications of medical DM have started to acknowledge the input of family 
caregivers in DM, clear delineation of family caregiver roles and dynamics within the DM process 
remain largely unexplained.  
A limited number of more specific conceptual descriptions of family caregiver involvement in DM 
have also been published. These conceptual descriptions have predominantly been typologies 
based on qualitative data, which describe how family caregiver involvement in the DM process 
varies along a spectrum from passive to dominant [16, 17, 23, 24]. Two triadic process models have 
also been proposed [25, 26], which posit how triadic interactions and patient outcomes (e.g. 
satisfaction, knowledge, and adherence) are influenced by factors including 
patient/family/clinician personality, knowledge, and attitudes. However, these existing 
descriptions do not capture the complex interactions and dynamics of all three participants 
(physician-patient-family caregiver) in the DM process.  
1.2 The issues with ‘ideal’ or ‘gold standard’ DM styles when caregivers are involved 
Besides Krieger [27], who proposed that aligned patient-family caregiver preferences for the 
extent of caregiver involvement in DM are preferable, there has been little prescription of ‘ideal’ or 
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‘gold standard’ forms or levels of family caregiver involvement in DM. Various ethical discussion 
papers have, however, proposed that there are preferred forms/levels of family caregiver 
involvement in DM; some advocating that individual patient autonomy should be maintained, with 
family caregivers assuming a supporting role [e.g. 28, 29], while others have suggested that family 
caregivers deserve to have an influential role in the DM process [5, 6, 30, 31], as they are often 
affected by the decision. Given the different ethical perspectives, and the fact that patient and 
family caregiver preferences vary widely, it is unlikely that there is a single ‘ideal’ or ‘gold standard’ 
model of family caregiver involvement in DM. However, delineation of the range of options in 
triadic DM may assist future discourse about which forms or levels of family caregiver involvement 
might be more appropriate, and why, in particular situations.  Furthermore, a flexible model that 
fits with what both the patient and family caregiver need, value and want - with 
consideration of the clinical scenario and input from the clinician - could be considered 
'ideal.' 
 
1.3 Aims    
To address persistent gaps in the conceptual literature, this paper proposes an empirically 
grounded framework of DM involving TRiadic Interactions in Oncology (TRIO Framework), 
which specifically aims to: i) depict the accommodation of family caregivers into the existing 
conceptualisation of clinician-patient DM; ii) explore the possible range of family caregiver 
influence over medical decisions and iii) describe the complexity and variability of family caregiver 
involvement in DM.  
1.3.1 Scope and purpose of the TRIO Framework  
The TRIO Framework focuses on the common scenario of one cognitively competent adult cancer 
patient, one key clinician (usually, but not restricted to, an oncology physician), and one key adult 
family caregiver (a person related to the patient biologically, legally, or emotionally, usually 
accompanying the patient to medical consultations and assisting in the patient’s care). The 
purpose of the TRIO Framework is to help characterise the involvement of family caregivers, and 
purposefully does not propose any ideal or preferred style of family caregiver involvement in DM.  
This Framework was developed based on cancer treatment DM, but is likely generalisable to other 
similar medical contexts.   
2. Methods 
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2.1 Conceptual framework development  
In this paper, a conceptual framework is defined as “a network, or a plane, of interlinked concepts 
that together provide a comprehensive understanding of a phenomenon” [32]. While the TRIO 
Framework development process was iterative and flexible in nature, it largely followed the eight 
main phases of conceptual framework development outlined by Jabareen [32].  
2.1.1 Phases 1-2: Mapping the selected data sources (Phase 1) was achieved through conducting a 
systematic review of empirical studies examining clinician-patient-family caregiver communication 
and DM [33] as well as reviewing relevant conceptual, ethical, and legal perspectives on family 
caregiver involvement in DM [34]. Relevant data from qualitative interviews with oncology 
clinicians, patients, and family caregivers [4] and interaction analyses of triadic consultation 
audiotapes [13], were also appraised. Extensive reading and categorizing of the selected data (Phase 
2) involved examining literature for relevant information to be included in the Framework. 
2.1.2 Phases 3- 6: Identifying and naming concepts (Phase 3) emerging from the literature and 
flexibly deconstructing, categorising (Phase 4) and then integrating (Phase 5) concepts with 
similarities to develop new overarching concepts was conducted. Phase 6 involved the synthesis of 
concepts into a theoretical framework. As highlighted by Jabareen [32] this phase is “iterative and 
includes repetitive synthesis and resynthesis until the researcher recognizes a general theoretical 
framework that makes sense”. Phases 2-6 were initially conducted by RL-P, PB, and IJ during a 3-day 
intensive workshop. A draft Framework was then sent to CC, AG, VE, and RE, who provided written 
feedback and engaged in teleconference discussions. The TRIO Framework underwent several 
subsequent iterations, with all co-authors providing written feedback and engaging in 
teleconference/email discussions for each draft.  
2.1.3 Phase 7: Validating the conceptual framework was achieved using multiple methods. The 
Framework was applied to: i) empirical examples of family caregiver involvement in DM derived 
from interviews with health professionals, patients, and family caregivers [4] and ii) audiotaped 
oncology consultations [13] to test its scope to accommodate a variety of triadic DM styles and 
behaviours. As recommended by Jabareen [32], the TRIO Framework was presented at relevant 
conferences (International Shared Decision-Making Conference, Sydney, Australia, 2015; European 
Association of Communication in Healthcare Conference, Heidelberg, Germany, 2016; Clinical 
Oncology Society of Australia, Hobart, Australia, 2015) to test its acceptability and usefulness 
among researchers and clinicians. Feedback was incorporated into the TRIO Framework. The 
acceptability of the corresponding graphical aid (the TRIO Triangle), and its validity in conveying 
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triadic dynamics, was tested and established in a study among undergraduate psychology students 
[35]. 
2.1.4 Phase 8: Development of the conceptual framework remains ongoing as “a theoretical 
framework representing a multidisciplinary phenomenon will always be dynamic and may be revised 
according to new insights, comments, and literature” [32].  
 
3. Results 
3.1 The TRIO Framework 
At the core of the TRIO Framework are six important conceptual insights (Concepts) derived from 
our program of empirical research and the wider evidence base. They include: 
Concept 1:  Family caregiver influence over a decision is variable amongst different groups 
Concept 2:  Family caregiver influence is variable within the one triad over time  
Concept 3:  Family caregivers are involved in various ways in the wider DM process 
Concept 4:  DM is not only amongst three, but can occur among wider social networks 
Concept 5:  Many factors may affect the form and extent of family caregiver involvement in DM 
Concept 6: Family caregiver influence over, and involvement in, DM is linked to their everyday   
involvement in illness care and management 
 
The empirically-derived conceptual insights, which underpin the TRIO Framework, will be further 
described throughout this paper, with some being graphically conveyed using a triangle (the TRIO 
Triangle) to aid readers’ understanding. A triangle (see Figure 1) was chosen as it accommodated 
the triadic nature of DM between the patient, key clinician, and key family caregiver. Triangles have 
previously been used to convey the clinician-patient-family relationship [see 36]. The TRIO Triangle 
should be considered as a tool to understanding some aspects of the wider and more 
comprehensive TRIO Framework.  
 
3.2 Family caregiver Influence: Development of the TRIO Triangle 
Within the clinician-patient dyad, influence over a medical decision is often presented as varying 
along a spectrum, ranging from ‘paternalism’ (clinician-led DM) to the ‘informed’ approach 
(patient-led DM). Shared DM between the clinician and patient has commonly been placed in the 
‘middle’ of these two ‘anchor points’ [e.g. 37]. However it is clear that a family caregiver could not 
fit along this unidimensional line. Our [4, 13] and others’  [e.g. 4, 13, 16, 17] empirical work points 
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to the fact that, in many cases, a family caregiver is influential in the DM process, and their 
influence over a decision can similarly rest on a spectrum from passive, to shared, to dominant.   
Based on this we propose that, instead of a unidimensional line (see Figure 1, Section 1), a triangle 
is a more appropriate starting point to capture and express the complex scope of clinician-patient-
family caregiver influence over a decision (see Figure 1, Section 2).  It is proposed that each of the 
three points of the triangle represent the dominant influence of a specific individual during a DM 
interaction (e.g. clinician-led DM; patient-led DM; or family caregiver-led DM).  
The TRIO Triangle also depicts the dyadic sharing of influence over a decision between two parties 
at the midpoint between two points of the triangle (i.e. shared clinician-patient DM; shared 
clinician-family caregiver DM; shared patient-family caregiver DM). The triadic ‘equal’ sharing of a 
decision between all three parties is located at the very centre of the triangle space (i.e. triadic DM 
between the patient, key clinician, and key family member) (see Figure 1, Section 3). The positioning 
of the clinician at the apex of the triangle was purposeful, given that they typically hold dual roles 
within triadic DM, namely: i) as a participant within the DM process and ii) as the facilitator of 
triadic DM discussions within consultations, having the medical expertise and a professional role in 
the DM process. 
An important point raised by Charles et al. [37] was that, in reality, clinician-patient DM does not 
exist only in these ‘pure’ or ‘extreme’ approaches (i.e. paternalistic approach, shared approach, 
informed approach). Rather, a multitude of intermediate/hybrid approaches exist along the uni-
dimensional line. Similarly, we propose that real clinician-patient-family caregiver influence over a 
decision is likely to rest somewhere within the triangle space as an intermediate/hybrid approach 
existing within a spectrum (see Figure 1, Section 4), versus the 7 “pure” approaches depicted by 
the points and mid-points of the triangle.  
 
3.3 A comment on influence vs. involvement 
The TRIO Triangle and Concepts 1 (family caregiver influence over a decision is variable amongst 
different groups) and 2 (family caregiver influence is variable within the one triad over time) 
discuss and depict the notion of family caregiver ‘influence’, that is, lead contributions to the 
shaping of the medical decision. Influence is  conceptualized in the Triangle as being relative, where 
the more influence one party has- the less influence the others can have over a decision. There can, 
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however, be points of equilibrium and sharing of influence, which are denoted in the TRIO Triangle 
as shared dyadic and shared triadic DM.  
Whilst family caregiver influence is the primary focus of the TRIO Triangle and Concepts 1 and 2, in 
other elements of the Framework we acknowledge (and where possible comment on) the wider 
concept of family involvement in the DM process. Involvement in DM can manifest in varied ways, 
including the more obvious/concrete family caregiver involvement in information exchange (e.g. 
researching treatments, providing information, questioning options) and deliberation (e.g. 
providing an opinion, explicitly stating support of patient preferences), but also in more 
subtle/abstract ways as proposed by Entwistle and Watt [38], such as a ‘sense of being a part of’ a 
decision, a ‘commitment to being there for’ the patient during DM, or ‘being significantly impacted by’ 
the decision. The broader concept of family caregiver involvement will be discussed in Concepts 3-6.    
[INSERT FIGURE 1 HERE]
The six empirically-grounded conceptual insights (Concepts) that form the core of the TRIO 
Framework will now be outlined in detail. 
3.4  Concept 1: Family caregiver influence over a decision is variable amongst different groups 
An important empirical finding within the evidence base [4, 13, 16, 17] was the variability of family 
caregiver influence among triads. For example, in some cases the family caregiver was very passive 
and did not influence the decision whilst the patient and clinician shared the decision; in other 
triads, the family caregiver assumed a dominant role in DM while the patient and clinician had 
limited input.  
“So there are times when patients will actually say, “Look, just ask him”, or, “Ask her, I just 
don’t feel like I can make another decision”. So it really depends where they’re at---“ Nurse [4]. 
Figure 2 provides case examples of three different triadic dynamics, to illustrate this variability 
amongst triads.  
[INSERT FIGURE 2 HERE] 
3.5 Concept 2: Family caregiver influence is variable within the one triad over time 
In addition to among-triad variability, existing empirical literature points to the dynamism of 
family caregiver involvement within the one triad over time. For example, patients in our 
qualitative study reported that their family caregiver’s influence over decisions evolved throughout 
10 
   
the illness trajectory, where sometimes caregivers were required to take a more influential role in 
the DM process, and at other times they assumed a more passive role, as the patient’s needs and 
abilities fluctuated over time [4], thus, the role of a family member: 
 “will vary in the situation and it might vary even at different consultations. … It’s a moveable 
dynamic”. [4] 
To highlight the changing nature of family caregiver influence over decisions within the one triad, a 
case example is provided in Figure 3, where points A, B, C, D, and E represent different decision 
points within one patient’s illness trajectory.  
[INSERT FIGURE 3 HERE] 
3.6 Concept 3: Family caregivers are involved, in various ways, in the wider DM process 
As highlighted in Concepts 1 and 2, family caregivers may exert influence over the decision to be 
implemented, and this level of influence may differ amongst different triads and within the one 
triad over time. In addition, our research has found that family are commonly involved in the DM 
process in many ways across the various  stages of DM [4]. See Table 1 for supporting quotes. 
For example, family caregivers may be involved in: i) pre consultation preparation (e.g. 
researching which doctor to see, reading results of scans, preempting treatment options and 
discussing these with the patient); ii) information exchange (e.g. gathering/contributing 
information about treatments; asking questions; recalling information; providing medical 
information about the patient; providing social information about the patient/ themselves; 
questioning information provided by the clinician); and iii) deliberation (e.g. acting as a ‘sounding 
board’; supporting and advocating for the patient’s wishes; undermining the patient’s preferences; 
providing own opinions/preferences). It is through these behaviours/actions that family caregivers 
often exert influence over a decision, which can be perceived as positive, negative, or neutral 
contributions to the DM process. In addition, some of these family caregiver actions may also 
achieve other outcomes such as providing the patient with comfort and support, enhancing (or 
undermining) the patient’s autonomy, and/or reassuring the clinician that the patient has had 
adequate support when making a decision.  
 
Table 1 about here 
  
3.7 Concept 4: DM is not only amongst three 
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One patient, one key clinician, and one key family caregiver were the most commonly reported 
participants involved in consultations and DM discussions in our series of qualitative studies [3, 4, 
39]. However, the wider ‘social networks’ of each of these key stakeholders may also be involved in 
the DM process and influential over the final decision, including other patients, family members, 
health professionals, friends, and neighbours [17, 40]. In addition, a growing body of evidence is 
recognising that clinicians also exist within interprofessional networks, and other clinicians, allied 
health team members, and healthcare administrators may inform the clinician’s position within the 
DM process [41-43]. Indeed, the involvement of other health professionals is well documented in 
situations where complex medical decisions are discussed at multidisciplinary team meetings  [e.g. 
44].  
These findings align with Epstein and Street’s [20] concept of ‘shared mind’ decision processes, 
particularly the notion that decisions are made within social networks. Recognising that patients 
often discuss decisions with trusted family, friends, and clinicians before and after consultations, 
Epstein [45] proposed that it is important to recognise these complex social networks and how they 
can affect DM, as their involvement and influence may not be outwardly apparent, particularly in the 
consultation environment.  
Figure 4 depicts a sociogram, a simplified version of a social network analysis  which depicts 
hypothetical interrelationships among networks of key individuals [46]. More specifically, it 
highlights that, while there is usually a core ‘triad’ of individuals involved in a decision, many other 
individuals may exist within a wider social network. In Figure 4, the patient and family caregiver 
networks are purposefully intertwined, as it is likely they will share a number of influential family 
members and friends.  
[INSERT FIGURE 4 HERE] 
3.8 Concept 5: Many factors may affect the form and extent of family caregiver involvement in 
DM 
A number of factors (e.g. demographic, psychological, relational, cultural, and medical) may impact 
on the type of involvement family caregivers assume and the level of influence they have over a 
decision. See Table 2 for supporting quotes from our qualitative study [4]. 
The demographic characteristics of patients and family caregivers (e.g. age, gender, education 
level, health literacy [[47] may have an impact on caregiver involvement. For example, one study 
noted that family caregivers are more likely to be actively involved in DM when patients were 
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older or female, perhaps due to gender roles [18].  Oncology clinicians in our groups’ qualitative 
study also proposed that family caregivers may assume a greater role in DM when the patient was 
younger or older (rather than middle aged) and/or had a lower level of education while more 
actively involved caregivers tend to be middle aged, female, and well-educated [4].  
Psychological characteristics of participants, such as their mental health, coping, and personality 
traits may also impact upon the extent of family caregiver involvement. For example, Street and 
Gordon [2] found a non-significant trend for family caregivers of patients reporting better mental 
health to be less active in the consultation, and in our work [4], oncology clinicians reported that for 
patients with mental illness such as depression or anxiety, or with ‘withdrawn’ personalities, 
family caregivers had greater involvement and influence over decisions. These oncology 
clinicians posited that such psychological characteristics increased patient vulnerability, 
and made it more difficult for them to self-advocate or speak up in consultations. Other 
literature suggests that psychological empowerment correlated with older adults’ preferred 
and perceived involvement in medical decision-making [47].  
The history and general nature of the relationship between participants, particularly between the 
patient and family caregiver, may also impact on the level of caregiver involvement and their 
subsequent influence. For example, family caregiver involvement in DM is increased among 
married/de-facto patient-caregiver pairs compared to other caregivers [11, 18], and when 
caregivers report a close and strong relationship with the patient [4].  
Cultural and societal factors, such as cultural norms or language ability, may also impact on the 
extent that family caregiver input is desired and considered appropriate.  For example, it has been 
found that families were typically more involved and influential if the patient was of Chinese decent 
[18] or if the caregiver or patient was a migrant from a non-English speaking country [4]. Social 
support provided to the family caregiver by others in the wider circle may also influence 
caregiver capacity to be involved in decision-making [48]. 
The nature and severity of the disease may also influence family caregiver involvement. Family 
caregivers are more likely to be involved in DM for patients with more severe/advanced illnesses 
(e.g. advanced cancer) compared to milder or more short-term illnesses/injuries (e.g. ear infection) 
[11, 49]. 
Finally, the nature and significance of the decision may influence the extent of family caregiver 
involvement. Oncology clinicians proposed that family caregivers may be more involved when the 
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decision is complex, significant, or when the caregiver is heavily impacted by the decision [4]. For 
example, for cancers in which there are more innovative / cutting edge treatments available and 
outcomes are still uncertain, patients may look to family caregivers more to support their decision-
making versus for cancers with fewer treatment options [50]. Likewise, family caregivers may 
have more input into  treatments such as stem cell transplant given the intense nature of this type 
of treatment and recovery.[51, 52]. However to our knowledge no studies have quantitatively 
tested this within the triadic context.  
Table 2 about here 
3.9 Concept 6: Family caregiver influence over, and involvement in, DM is linked to their 
everyday involvement in illness care and management 
Empirical work by our group in Australia [4] highlights that family caregivers can assume a range 
of roles within and beyond the medical consultation (e.g. provision of emotional support, assistance 
with information, transportation, medication management, home-based medical care, assistance 
with activities of daily living, financial support). These, and the many other roles, which family 
caregivers may assume throughout a patient’s illness, may foster and be examples of the more 
subtle types of involvement in a decision, as proposed by Entwistle and Watt [38], which may be 
considered as valuable contributions to patient care in their own right, as well as potentially 
influencing the DM process in an indirect manner.  
4. Discussion and conclusion 
4.1 Discussion  
The TRIO Framework provides the first comprehensive description of family caregiver 
involvement in, and influence over, cancer treatment decisions. It has been rigorously developed, 
informed by our own program of research [4, 13, 33]; as well as a comprehensive review of other 
relevant empirical, conceptual, ethical, and legal publications, and iterative feedback from an 
advisory group of experts in ethics, medical oncology, psychology, and theory development.  These 
strong empirical foundations underpinning the TRIO Framework enhance the validity and clinical 
relevance of the TRIO Framework, with several empirical examples derived from our interview [4] 
and consultation transcript [13] studies used to test the Framework’s effectiveness in depicting the 
real behaviours and dynamics occurring during triadic DM. 
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A key strength of the TRIO Framework is that the focus on family caregivers is explored in the 
wider context of the clinician-patient-family caregiver triad. Through use of conceptual insights 
and graphical aids (TRIO Triangle), the TRIO Framework is able to describe some of the complex 
interactions and dynamics of all three core participants (patient, key clinician, key family caregiver) 
in the triadic DM process. More specifically, the TRIO Framework describes a number of 
empirically-grounded conceptual insights relating to family caregiver influence and involvement in 
the DM process, such as the variability of caregiver influence within and among groups, the wider 
social networks (beyond the triad) involved and invested in the DM process, the array of contextual 
factors which may affect the extent of caregiver involvement in DM, and the interrelationship 
between caregivers’ roles in everyday illness management and DM.  
The TRIO Framework has purposefully examined both the narrower concept of family caregiver 
influence over a decision, as well as the broader concept of family caregiver involvement in the DM 
process, including information exchange, deliberation and making the actual decision. These 
concepts were purposefully teased apart to highlight the many roles and impacts family caregivers 
have when involved in DM. In some cases, family caregiver involvement in DM is clearly linked to 
their level of influence over the final decision. For example, the wife of a prostate cancer patient 
researches which cancer treatment centre her husband should attend, provides him with 
information about the cancer and potential treatments, actively engages in the consultation 
discussions, and clearly articulates her preferences for a particular course of treatment, while the 
patient listens to his wife, takes into account all of her recommendations, and decides to receive the 
treatment she advocates. However, in many cases, family caregivers may be heavily involved in the 
DM process, but have limited influence over the final treatment to be implemented. For example, the 
adult son of a breast cancer patient researches and provides information about treatment options, 
attends consultations, acts as a sounding board when the patient is deliberating over the decision, 
and helps arrange the logistal aspects of her treatment, while the patient strongly believes it is “her 
body, her decision” and makes the decision for treatment independent of her son’s preferences. This 
approach to family caregiver involvement in DM was commonly discussed by participants in our 
groups’ qualitative study [4], with one family caregiver stating “[Patient] pretty much made [the 
decision] by herself . . . I deliberately wouldn’t have influenced the decision. So in a lot of ways it was 
“how could I make it easier for her?” or “how could I facilitate the process of her making the decision?”. 
Therefore, it is important for researchers and clinicians to not only consider the extent of family 
influence over the decision that a patient may prefer, but also the type and amount of family 
involvement in the broader DM process.  
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The TRIO Framework is likely to be useful in several ways. First, it provides an empirically-based 
platform for depicting the scope of triadic influence in medical DM, and may be a useful guide for 
further research in the area. Indeed, the TRIO Triangle itself could be conceptualised as a map to 
help understand the complex landscape of the family caregiver’s relative influence over a decision. 
For example, it may form the basis of ethical,legal, and clinical discussions debating whether some 
areas of the triangle are preferable in certain contexts (e.g. for patients with dementia, adolescent 
patients, fertility treatment DM) and when approaches taken by any member of the triad conflicts 
with that taken by another member, such as an assertive patient encountering a paternalistic 
physician or a caring but misguided family caregiver tries to direct a patient’s choice.  
In addition, by depicting a spectrum of family caregiver influence in DM, the TRIO Framework 
could be used to educate health professionals about the diverse and varying scope of family 
caregiver involvement and influence. This Framework also highlights that, in reality, there are 
many intermediate and nuanced styles that lie between the seven ‘pure’ styles. The identification of 
intermediate styles  increases options for clinicians when they are discussing family caregiver 
involvement with patients (and potentially caregivers). Additionally, the point that DM styles may 
vary across an illness experience reinforces the importance of flexibility so that clinicians are able 
to recognise and respond to the evolving preferences and behaviours of patients and family 
caregivers over time. The identification of influencing factors also highlights that one factor (e.g. 
patient age or culture) is unlikely to solely influence the extent of family caregiver involvement; 
rather a complex web of factors are likely to influence DM styles. Clinicians should thus avoid 
assumptions based on a single characteristic of the patient or caregiver (e.g. all wives want to be 
heavily involved in DM). With further research and validation, a simplified form of the triangle 
could be useful in obtaining patient and/or family caregiver preferences for triadic DM dynamics.  
As highlighted in Concept 6, a family caregiver’s involvement in DM may be underpinned by their 
broader participation in the everyday care and management of the patient’s illness, such as 
emotional support, practical/logistical support, and home-based medical care. Indeed, many of the 
conceptual insights in the TRIO Framework, such as Concept 1 (family caregiver influence over a 
decision is variable among groups), Concept 2 (family caregiver influence is variable within the one 
triad over time), and Concept 5 (many factors may affect the form and extent of family caregiver 
involvement in DM) apply not only to the narrower concept of treatment DM, but to many aspects 
of the much broader concept of illness care and management. For example, the amount and type of 
home-based medical care a family caregiver provides is likely to vary throughout the course of an 
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illness (e.g. more active caregiver involvement during flare-ups) and is likely to be influenced by a 
number of contextual factors (e.g. the nature/closeness of the patient-family caregiver relationship,  
cultural expectations about caregiver roles).  
Whilst the TRIO Framework focuses on family caregiver involvement when a patient is cognitively 
competent, many of the conceptual insights may also apply in situations where a patient has 
impaired cognitive capacity (e.g. early stage dementia, mild intellectual disability). Cognitive 
capacity should not be thought of as a dichotomous construct, but rather a more complex construct 
existing along a continuum from low to high cognitive ability, varying depending on the complexity 
of the decision, and able to fluctuate over time [e.g. 53]. Indeed, it has been argued that seriously ill 
(but legally cognitively competent) patients are also often cognitively compromised in subtle ways- 
facing a potentially terminal illness can result in cognitive biases and difficulty assimilating complex 
information. The facilitative and supportive behaviours of family caregivers discussed in Concept 4 
(e.g. within a consultation asking questions, recalling medical information, providing information 
about the patient, acting as a ‘sounding board’, advocating for the patient’s wishes) and Concept 6 
(e.g. providing emotional support, transportation, medication management, home-based medical 
care, financial support) may be particularly vital in situations where patients have impaired DM 
abilities, to encourage and enhance enactment of the patient’s wishes.  A model of ‘supported 
decision-making’, clearly outlining helpful behaviours and steps for family caregivers to enhance 
the autonomy of patients with cognitive impairment, may be a valuable future addition to the 
evidence base.   
Whilst a number of exciting opportunities exist for application and extension of the TRIO 
Framework, further discourse and research is needed to fully understand its relevance and reach. 
For example, research to validate the Framework could test its fit for a series of specific 
cases with varied individuals, decisions, and contexts. Interventions based on the 
Framework could also be evaluated to determine whether they alter placement within the 
TRIO triangle in ways concordant with patient, family member and clinician preferences. 
 
4.2 Limitations    
The TRIO Framework characterizes important aspects of family caregiver involvement in DM, 
however it also has some limitations. As the TRIO Triangle focuses on the core ‘triad’ (patient, key 
clinician, key family caregiver), it would need to be expanded to adequately represent more 
complex situations and those involving larger social networks, such as when there are two or more 
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family caregivers who occupy important roles. Further development of the TRIO Framework will 
be needed to capture more complex relationship dynamics among the parties in the triad such as 
conflicts, undue family influence, and coalition formation.  
4.3 Conclusion   
This paper proposes the TRIO Framework, which provides an expanded representation of medical 
DM styles, accommodating the influence and involvement of family caregivers. We believe that this 
conceptual framework will help to guide future DM research, and also to deepen health 
professionals’ and researchers’ understanding of the array of possible triadic DM dynamics, inside 
and outside the consultation. Given the many (practical, theoretical, ethical, legal) complexities of 
triadic DM, our conceptualisation and articulation of family caregiver involvement in the DM 
process, and their ultimate influence over the decision to be implemented, is likely to continue to 
evolve based on emerging evidence and new perspectives. 
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Figure 1: Developing the TRIO Triangle 
5. The beginnings of a conceptual framework: 
Starting from the dyad 
The starting point of our graphical conceptualisation 
of DM was the dyadic (clinician-patient) spectral line, 
with clinician-led DM (paternalistic approach) at one 
extreme, patient-led DM (informed approach) at the 
other extreme and shared clinician-patient DM 
(shared DM approach) depicted as the black dot in 
the middle.   
 
However, our team perceived limited space for 
caregivers on this line, and therefore expansion was 
deemed necessary.  
 
 
6. Expanding the clinician-patient 
conceptualisation to include caregivers  
Our team proposes that a triangle best depicts the 
dynamics of the clinician, patient, and key family 
caregiver influence over a decision. In this graphical 
depiction, each anchor point (black dot) of the 
triangle represents an ‘extreme’ or ‘pure’ position, 
where one party has dominant influence over a 
decision.   
  
 
 
 
 
 
 
 
7. Introducing shared approaches within a triad 
Just as shared DM can be positioned at the midpoint 
of the clinician-led and patient-led approaches in 
dyadic DM (see section 1), so too can shared 
approaches be positioned within the midpoints of the 
TRIO Triangle. It is important to note that just 
because all three parties have the potential to exert 
influence over a decision, it does not mean that they 
will do so. Therefore, the three mid-line points on the 
TRIO Triangle represent three-types of dyadic shared 
DM that might exist when three parties are involved 
(clinician-patient; clinician-caregiver; or patient-
caregiver).  
  
In addition, the midpoint in the triangle space 
represents the sharing of DM influence between all 
three parties, representing shared triadic (clinician-
patient-caregiver) DM.  
 
However, in reality, it is unlikely that any of these 7 
depicted approaches exist in their pure form. Like 
Charles et al. [48] proposed, DM in the real world will 
be a more complex hybrid mix of these theoretical 
extremes. 
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4. Caregiver influence as a spectrum 
We propose that, in the real world, the dynamics of 
influence over a decision between a patient, key 
clinician, and key family member are likely to rest 
somewhere within the triangle space as an 
intermediate style. It is conceptualised that DM when 
a caregiver is present rests on a triadic spectrum 
which can shift from dominant influence of one 
individual (triangle point- e.g. clinician-led DM) to 
complete triadic sharing of the decision (triangle 
centre- shared triadic DM). The influence of a 
caregiver in DM may rest in any position within this 
triangle space. 
  
 
 
 
 
 
 
  
Clinician-led  
Caregiver-led 
 
Shared     
clinician-patient 
 
Shared       
clinician-caregiver 
 
Shared       
patient-
caregiver 
 
Patient-led 
 
Shared triadic 
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Figure 2: The variability of caregiver influence amongst different triads 
 
Example 1:  is plotted at a point which represents 
sharing of a decision between the patient and 
clinician, with a very small degree of caregiver 
influence. 
 
Example 1 could be the case of a patient with 
advanced cancer facing a decision of whether to 
receive chemotherapy or no treatment. The patient 
and oncologist share information, each contribute 
their preferences during deliberation, and the 
decision is shared between the patient and clinician.  
The patient’s adult daughter states that, while she 
wants her father to live as long as possible, she will 
support whatever his decision is. The patient and 
clinician have most influence over the decision, and 
the caregiver has a small amount of influence 
although she shares her general preferences.  
  
 
 
Example 2: is plotted at a point which represents 
that the patient has greatest influence over the 
decision (as indicated by the shortest distance on 
the arrow leading from the patient-led anchor 
point), followed by the caregiver with limited input 
of the clinician.  
 
Example 2 could be the case of a young adult woman 
diagnosed with breast cancer who is facing the 
decision of whether to delay chemotherapy to 
undergo fertility treatment. Whilst the patient 
retains most of the DM control, outside of the 
consultation she and her husband research and share 
information and deliberate together, where the 
husband shares his preferences of wanting children 
and his willingness to undergo IVF but clearly states 
that it is ultimately her body and her decision. The 
couple discuss the decision with a clinician, but feel 
strongly it is their own personal choice.  
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Example 3: is plotted at a point which represents 
that the caregiver has greatest influence over the 
decision (as indicated by the shortest distance on 
the arrow leading from the caregiver-led anchor 
point), followed by the clinician with very limited 
influence of the patient.  
 
Example 3 could be the case of a patient with limited 
English language proficiency who is diagnosed with 
lung cancer. His son (fluent in English) directs the 
information exchange with the clinician in all 
consultations and translates a small amount of the 
information for the patient. The son directs the 
deliberation process, not conveying the patient’s 
wishes. The treatment decision is largely directed by 
the patient’s son, to which the patient consents.  
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Figure 3: The variability of caregiver influence within the one triad over time 
The following is a case example of the variability of 
caregiver influence over a number of decisions within 
the one illness experience.  
 
A person suffers from a seizure and becomes 
unconscious at work and is brought to the emergency 
room where the responsible clinician orders a number of 
diagnostic tests and treatments on the patient’s behalf 
(A).  
  
The patient’s spouse is called and is informed that the 
patient has had a large brain bleed caused by a brain 
tumor and will require surgery. The clinician and spouse 
share the decision to operate immediately (B).  
  
The surgery is successful and after a period of time the 
patient regains consciousness. The patient is informed of 
their diagnosis of a brain tumor and radiotherapy is 
discussed and decided upon between the patient, 
clinician, and spouse (C).  
  
After the patient is discharged from hospital, the patient 
and spouse begin researching steroid therapy. They 
discuss this decision at length at home sharing their 
information, opinions and preferences. The patient and 
spouse make a decision together with limited input from 
a clinician (D).  
 
After a period of time, the patient’s cancer recurs in the 
brain. The patient researchers the implications of this 
recurrence, deliberates alone, and makes the decision, 
relatively independently of his spouse and clinician, to 
cease treatment (E).  
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Figure 4: A hypothetical social network involved in a medical decision
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Table 1: Stages of decision-making in the triad: Illustrative quotations  
 
Pre consultation 
 And I said look there’s also this other doctor….  let’s research him, so I researched him and found out that he was 
super duper--- Family member  
 We had already made up our mind before we went in there--- Family member 
Information exchange 
 When she was looking at alternative therapy I was a little bit concerned about what she was considering… So I 
researched it myself and got more information and suggested that she discuss it with the oncologist--- Family 
member 
Deliberation 
 Where it wasn’t a clear cut path I think that it's sort of been a dialogue and… sort of a Socratic (method) in a way 
that it goes back and forth and back and forth and eventually...the pathway does sort of emerge--- Patient  
Decision 
 I think in about 90% of situations, it will be the patient who verbally says, “I will do this, or I will do that”. [The 
family will say]…”What do you think, Dad? What are you going to do?”. --- Medical Oncologist.  
  
Follow up 
 I believe the concept of revisiting the decision is about reassuring yourself that you’ve made the decision that's best 
for you before it becomes irrevocable… Sometimes you will revisit that decision because you come up with new 
information… my role there was to listen very carefully and when it was needed to annunciate what this 
information really meant for what we had decided and then discuss whether we felt we needed to change the 
decision--- Family member 
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Table 2:  Characteristics influencing family involvement: Illustrative quotations  
 
Patient characteristics 
 I think it [family involvement] is just a very individual thing. I think the gender comes into it... Your generation 
comes into it and ethnicity comes into it. They all impact--- Oncology Nurse 
 
 I think it’s the more needy patients [who have active family involvement] – the very young and the very old are the 
most common, or the ones who are physically debilitated and needing the care for physical reasons. And then 
finally, those who either have a mental health disorder or severe anxiety or depression. --- Medical Oncologist 
 
Relationship characteristics 
 If you are a family member and you are close to that person – if you are a parent or a wife or a spouse or a child…– 
there’s this real feeling of keeping them alive. When it’s an elderly lady and their niece comes along, and that’s sort 
of a bit more remote, then you tend to find the decisions are different, and the conversation is a little bit different--- 
Oncology Nurse 
 
Decision characteristics 
 So decisions that are big, complex decisions with long-term ramifications, you need help. I think we all need to be 
able to… give ourselves some certainty that we’re making the right decision, and it’s hard to do that in isolation--- 
Medical Oncologist 
 
 When it’s just operation or not, there is no real decision making then. It’s really perhaps nice to have them [family] 
there, but there are no decisions… It’s really ‘do you want to die or do you want to have the operation and have a 
chance of living?’.. But in the ones where there is a decisional conflict, then I think [family involvement is] even more 
helpful--- Surgical Oncologist 
 
